Two-Day Multiplexing Technology Symposium Brings Together Thought Leaders in Life Sciences and Clinical Diagnostics to Share Ideas and Best Practices
OOSTERHOUT, Netherlands, Sept. 13 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX), the world leader in multiplexed solutions, today announced the agenda for Planet xMAP Europe 2007, the company's annual European end-user technology symposium. The two-day event will be held 2-3 October at the Berlage's Exchange in Amsterdam, the Netherlands, and will feature a range of presentations regarding Luminex's flexible xMAP(R) multiplexing technology in clinical diagnostics and life science research applications.
"We are thrilled to welcome xMAP technology end-users back to The Netherlands for our fifth annual Planet xMAP Europe," said Paul C. Ladestein, Director of European Operations for Luminex. "This event will allow scientists, researchers and clinicians to come together to share best practices and ideas not only about xMAP technology, but about the broader role that multiplexing technology is playing to improve research and enhance the quality of patient care."
Planet xMAP Europe 2007 will feature two days of presentations and workshops. Day One, Tuesday, 2 October, will concentrate on xMAP-based clinical diagnostics applications and include the following presentations:
-- Dr. John C. Carrano, Vice President, Research and Development Luminex Corporation (USA) - "xMAPing the Future: A Vision of Innovative Products and Dominant Solutions"
-- Dr. Susan J. Wong, Diagnostic Immunology Laboratory, Wadsworth Center NYSDOH (USA) - "Comparison of AtheNA Multi-Lyte Bb Microsphere Immunoassay to Two-Tier Serology for Laboratory Confirmation of Lyme Disease"
-- Dr. Mario J. Marcon, Director of Clinical/Molecular Microbiology, Virology, & Immunoserology, Department of Laboratory Medicine Children's Hospital, Columbus, OH (USA) - "Evaluation of the Plexus Epstein Barr Virus Panels in a children's Hospital Setting"
-- Professor Kai Zacharowski, M.D., Ph.D., Chair of Cardiovascular Anesthesia & Critical Care, Bristol Royal Infirmary (United Kingdom) - "Cytokines - From Head to Toe"
-- Dr. Diana Pauly, Center for Biological Safety, Microbial Toxins, Robert Koch-Institute (Germany) - "Simultaneous Detection of Bacterial and Plant Toxins Using a Multiplex Magnetic Bead Assay"
-- Dr. Gary T. Brice, United States Navy Medical Research Unit, Department of Immunology (Indonesia) - "Etiology of Respiratory Viral Pathogens in Suspect H5N1 Samples in Indonesia"
Day Two of Planet xMAP Europe 2007, Wednesday, 3 October, will focus on xMAP-based life science research applications and feature the following presentations:
-- Dr. Marion Lanteri, Postdoctoral Fellow, Immunology - "Cytokine Signature of Early Viral Infections"
-- Professor Thomas Herget, Ph.D., Director PLS R&D/New Technology Evaluation, Merck KGaA (Germany) - "Safety Biomarkers: Holy Grail of Toxicology"
-- Dr. Jochen Schwenk, KTH - Royal Institute of Technology, Alba Nova University Center, Department of Proteomics (Sweden) - "Multiplexed Approaches within Antibody Proteomics"
-- Dr. Corrado M. Cilio, Cellular Autoimmunity Unit, Department of Clinical Sciences and Pediatrics, Malmo University Hospital (Sweden) - "MicroRNA"
-- Dr. Oliver Poetz, NMI, Natural and Medical Science Institute at the University of Tuebingen (Germany) - "Magnetic Beads Work Better at Night"
-- Dr. Ben van Ommen, TNO Quality Life (The Netherlands), Head of Nutrigenomics and Nutritional Systems Biology Activities - "The Targeted Plasma Proteome in Personalized Health and Nutrition"
Luminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the diagnostic and life sciences industries. The Company's xMAP(R) multiplex solutions include an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics markets. The Company's xMAP technology is sold worldwide and is already in use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporation or xMAP can be obtained at http://www.luminexcorp.com.
Luminex Corporate Contact:
Harriss T. Currie
Vice President, Finance and Chief Financial Officer
Luminex Media Contact:
|SOURCE Luminex Corporation|
Copyright©2007 PR Newswire.
All rights reserved